European Biosimilar Regulatory Update | Goodwin : comparemel

In the past few weeks, the European Commission provided marketing authorization for biosimilars of denosumab and omalizumab, as well as an ophthalmic formulation of bevacizumab.

Related Keywords

United States , , European Commission , Committee For Medicinal Products Human Use , European Union , European Medicines Agency , Outlook Therapeutics , Bio Thera Solution , Medicinal Products , Human Use ,